Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
about
Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa.Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients.The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab EfficacyPrimary tumor site and anti-EGFR monoclonal antibody benefit in metastatic colorectal cancer: a meta-analysis.Current and future biomarkers in the treatment of colorectal cancer.The impact of primary tumor location on efficacy of cetuximab in metastatic colorectal cancer patients with different Kras status: a systematic review and meta-analysis.Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.Current and future biomarkers in colorectal cancer.Is the Location of the Tumor Another Prognostic Factor for Patients With Colon Cancer?First-line therapy for mCRC - the influence of primary tumour location on the therapeutic algorithm.ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.Differential expression of DUSP2 in left- and right-sided colon cancer is associated with poor prognosis in colorectal cancer.Tumor location impact in stage II and III colon cancer: epidemiological and outcome evaluation.
P2860
Q33706656-86F3EA4D-C73A-4561-AACA-C8F064AFB18EQ36218282-36F1228E-07FD-49D5-B556-26BB03480D84Q38668967-75798189-3C00-49B0-BC58-6D28FEECD984Q38734344-67FF25F7-E5F3-40A4-878A-2EAB79DD1853Q38767373-161A3B32-9F5C-474F-A980-AEFBE0A56B8AQ38787244-9A0E4780-9732-41F7-A32B-9AF47DBD8F8AQ41593315-6E5C773C-8B91-42BA-8659-6CC6298BC6C8Q42696314-AB0D17A2-721A-4EDC-8928-EF049103408AQ43492228-3B8EA8A9-1922-492E-80ED-B84ACB2B7AB7Q47550821-25762AD4-5989-4B6A-A540-86FB4D34467BQ48008504-AC36CB76-E7BA-4D56-AD06-6BBA1E135D96Q49691234-BEC37687-E44E-4BF8-8A43-C8BC55E89966Q52655173-CD738B3A-C6BC-4251-A647-33A9F85F6721Q55313926-4A6FEDF1-8CC4-425D-B568-97524765E05E
P2860
Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Location of Primary Tumor and ...... Metastatic Colorectal Cancer.
@en
type
label
Location of Primary Tumor and ...... Metastatic Colorectal Cancer.
@en
prefLabel
Location of Primary Tumor and ...... Metastatic Colorectal Cancer.
@en
P2093
P2860
P50
P1433
P1476
Location of Primary Tumor and ...... e Metastatic Colorectal Cancer
@en
P2093
Alessia Mennitto
Beatrice Borelli
Carlotta Antoniotti
Daniele Rossini
Federica Marmorino
Fotios Loupakis
Gabriella Fontanini
Gianluca Masi
Marta Caporale
Roberto Moretto
P2860
P304
P356
10.1634/THEONCOLOGIST.2016-0084
P50
P577
2016-07-05T00:00:00Z